Clinical Impact of a Digital Home-based Falls Prevention Program on Elderly People

NCT ID: NCT03750500

Last Updated: 2024-12-06

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

NOT_YET_RECRUITING

Clinical Phase

NA

Total Enrollment

100 participants

Study Classification

INTERVENTIONAL

Study Start Date

2025-05-31

Study Completion Date

2026-11-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study is a single-center, prospective, non-blind, parallel-group, randomized controlled trial with an experimental and a control group with the aim of evaluating the clinical impact of a home-based falls prevention program using a new biofeedback system on community-dwellers older adults with fall risk in comparison with standard of care.

The experimental group will perform a 12-week exercise program at home, under remote monitoring from a clinical team, whereas the control group will benefit from standard medical care currently in place at the participating primary care facility.

The hypothesis is that the home-based falls prevention program will lead to a lower risk of falling than standard medical care.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Fall

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

PREVENTION

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Experimental

Participants included in this arm will benefit from a 12-week exercise program using the novel biofeedback rehabilitation device, under remote monitoring from a physical therapist

Group Type EXPERIMENTAL

Biofeedback device

Intervention Type DEVICE

12-week exercise program performed through the device

Education on falls risk

Intervention Type BEHAVIORAL

Education on falls risk factors and how to minimize them

Medication review

Intervention Type OTHER

Medication will be reviewed to reduce sedative drugs and minimize interactions

Visual and auditory screening

Intervention Type DIAGNOSTIC_TEST

Patients will go through visual and auditory screening as part of their regular care

Standard of Care

Patients included in this arm will benefit from the standard of care currently in place in the Primary Care facility: education on risk factors for falls, medication review, visual and auditory acuity screening.

Group Type PLACEBO_COMPARATOR

Education on falls risk

Intervention Type BEHAVIORAL

Education on falls risk factors and how to minimize them

Medication review

Intervention Type OTHER

Medication will be reviewed to reduce sedative drugs and minimize interactions

Visual and auditory screening

Intervention Type DIAGNOSTIC_TEST

Patients will go through visual and auditory screening as part of their regular care

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Biofeedback device

12-week exercise program performed through the device

Intervention Type DEVICE

Education on falls risk

Education on falls risk factors and how to minimize them

Intervention Type BEHAVIORAL

Medication review

Medication will be reviewed to reduce sedative drugs and minimize interactions

Intervention Type OTHER

Visual and auditory screening

Patients will go through visual and auditory screening as part of their regular care

Intervention Type DIAGNOSTIC_TEST

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

SWORD Phoenix

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

1. Patients aged over 65 years old
2. Ability to walk at least 20 meters, unaided or with unilateral support
3. Ability to understand motor complex commands
4. Mini-Mental State Examination (MMSE) score \> 24 points
5. Functional independence for instrumental activities of daily living
6. Risk of recurrent falls, defined as 5xSST score \> 15,00 seconds

Exclusion Criteria

1. Patients residing in nursing homes, daycare units or assisted-living facilities
2. Aphasia, dementia or psychiatric comorbidity, significantly interfering with communication or compliance with a home-based exercise program
3. Severe visual our hearing, interfering with communication or with compliance to a home-based exercise program
4. Cardiac, respiratory or other condition incompatible with at least 30 minutes of light to moderate physical activity
5. Osteoarticular conditions (e.g. severe osteoarthrosis), which prevent the patient from complying with a home-based exercise program
6. Patients with neurologic conditions (e.g. stroke, multiple sclerosis, Parkinson's disease)
7. Other medical complications, which prevent the patient from complying with a home-based exercise program
8. Illiteracy
Minimum Eligible Age

65 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Sword Health, SA

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

USF Aldoar

Porto, , Portugal

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Portugal

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Fernando Correia, MD

Role: CONTACT

Phone: +351966557789

Email: [email protected]

Mariana Sant'Ana, MD

Role: CONTACT

Phone: +351918448914

Email: [email protected]

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Mariana Sant'Ana

Role: primary

Provided Documents

Download supplemental materials such as informed consent forms, study protocols, or participant manuals.

Document Type: Study Protocol, Statistical Analysis Plan, and Informed Consent Form

View Document

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

SH-RCT-FP-01

Identifier Type: -

Identifier Source: org_study_id